Vicki Kelemen's Insider Trades & SAST Disclosures

Vicki Kelemen's most recent trade in Cardiff Oncology Inc was a trade of 125,520 Stock Options done . Disclosure was reported to the exchange on March 15, 2023.

Share

Note

This is a custom search result for pattern Vicki Kelemen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Cardiff Oncology Inc	Vicki Kelemen	Exec. VP and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2023	125,520	698,304	-		-	Stock Options
Cardiff Oncology Inc	Vicki Kelemen	Exec. VP and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2022	170,016	572,784	-		-	Stock Options
Cardiff Oncology Inc	Vicki Kelemen	Exec. VP and COO	Purchase of securities on an exchange or from another person at price $ 10.31 per share.	23 Mar 2021	960	6,053 (0%)	0%	10.3	9,898	Common Stock
Cardiff Oncology Inc	Vicki Kelemen	Exec. VP and COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2021	70	5,124 (0%)	0%		0	Common Stock
Cardiff Oncology Inc	Vicki Kelemen	Exec. VP and COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2021	70	0	-		-	Restricted Stock Units
Cardiff Oncology Inc	Vicki Kelemen	Exec. VP and COO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	02 Jan 2021	31	5,093 (0%)	0%		0	Common Stock
Cardiff Oncology Inc	Vicki Kelemen	Exec. VP and COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share.	23 Nov 2020	35,321	40,375 (0%)	0%	2.5	87,596	Common Stock
Cardiff Oncology Inc	Vicki Kelemen	Exec. VP and COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Nov 2020	35,321	70,641	-		-	Stock Options
Cardiff Oncology Inc	Vicki Kelemen	Exec. VP and COO	Sale of securities on an exchange or to another person at price $ 18.60 per share.	23 Nov 2020	35,321	5,054 (0%)	0%	18.6	657,020	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades